Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance

Koksal A. S., Onder F. O., Torun S., Parlak E., Sayilir A., Tayfur O., ...More

ACTA GASTRO-ENTEROLOGICA BELGICA, vol.76, no.1, pp.34-37, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 76 Issue: 1
  • Publication Date: 2013
  • Journal Name: ACTA GASTRO-ENTEROLOGICA BELGICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.34-37
  • Keywords: Helicobacter pylori, eradication, treatment, quadruple, COLLOIDAL BISMUTH SUBCITRATE, CAMPYLOBACTER-PYLORI, SALVAGE THERAPY, INFECTION, ERADICATION, MANAGEMENT, GUIDELINES, TRIPLE
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

Background/Aims : Bismuth-containing quadruple therapy given four times a day is effective in the first-line treatment of Helicobacter pylori. We aimed to investigate whether twice daily posology could eradicate H. pylori at a comparable rate in an area with a high prevalence of antibiotic resistance.